Pharmala Biotech Holdings Inc. (MDMA.CN)

0.2300 +0.0200 (+9.52%) At close: 03:59PM EDT

Pharmala Biotech Holdings Inc.

1111 Melville Street
Suite 1100
Vancouver, BC V6E 3V6
Canada

https://pharmala.ca

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Nicholas Kadysh	Director, Pres and Chief Exec. Officer	N/A	N/A	N/A
Mr. Carmelo Marrelli ACIS, B.Comm., C.A., CGA, CPA	Chief Financial Officer and Corp. Sec.	N/A	N/A	1971
Dr. Shane Morris Ph.D.	Chief Operating Officer	N/A	N/A	1975
Mr. David Purcell	Director of Sales	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.

Corporate Governance

Pharmala Biotech Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.